-
Senate Approves Aid for Ukraine and Israel, Sending It to Biden’s Desk
The overwhelming bipartisan vote for the long-stalled $95.3 billion aid package capped a tortured journey for the legislation on Capitol Hill. President Biden is expected to quickly sign it.
-
Supreme Court to Examine Clash Between Idaho Abortion Ban and Federal Law
The case, which could reverberate beyond Idaho to other states with abortion bans, is the second time in less than a month that the justices have heard an abortion case.
-
Two Lawsuits, in Texas and Idaho, Highlight Fight Over Emergency Medicine Law
Federal trial judges in Texas and Idaho came to opposite conclusions in a battle between conservative states and the U.S. government over limits on abortion access.
-
How the Senate Voted on Foreign Aid to Ukraine, Israel and Taiwan
The measure, which includes a provision on the sale or ban of TikTok, had wide bipartisan support.
-
Here’s How U.S. Aid to Ukraine Might Help on the Battlefield
Weapons from the aid package, considered “a lifeline” for Ukraine’s military, could be arriving on the battlefield within days.
-
Unpacking the Power of Movie Soundtracks: How Music Enhances the Film Experience
Lights dim, the screen flickers to life, and the opening credits begin to roll. As the first notes of the movie soundtrack hit our ears, we are transported into a world of storytelling and emotion. Movie soundtracks have the power to elevate the film experience, taking us on an emotional journey and immersing us in…
-
Doing Life Sciences Deals in 2024
Nearly one hundred life sciences professionals convened at Mintz’s Boston office last week for an event we hosted in partnership with the LES (Licensing Executives Society). I moderated a panel, “Structuring Your Life Sciences Transaction: Licensing vs. M&A vs. Asset Sale,” with business development leaders from GSK, Johnson & Johnson, Locust Walk, and Astria Therapeutics.…
-
USPTO Issues Guidance on AI Use to Patent Professionals — AI: The Washington Report
Pursuant to President Biden’s October 2023 executive order on AI, on April 11, 2024, the United States Patent and Trademark Office (USPTO or Office) published “Guidance on Use of Artificial Intelligence-Based Tools in Practice Before the United States Patent and Trademark Office” in the Federal Register. This notice provides insight into the USPTO’s current stance…
-
Recent Ransomware Attacks Highlight the Evolving Challenges in Responding to Cyber Extortion
A spate of recent ransomware attacks illustrates the increasingly difficult calculations that businesses face following the theft or encryption of their data….By: Patterson Belknap Webb & Tyler LLP
-
Federal Circuit Patent Watch: District Court’s “Seemingly Siloed and Inflexible Approach” to Obviousness “Ran Afoul” of KSR
Precedential and Key Federal Circuit Opinions – 1. JANSSEN PHARMACEUTICALS, INC. v. TEVA PHARMACEUTICALS USA, INC. [OPINION] (2022-1258, 2022-1307, 4/1/2024) (Dyk, Prost, and Hughes) – Prost, J. The Court affirmed the district court’s indefiniteness determination but vacated and remanded its nonobviousness determination as to the asserted patent….By: WilmerHale
